Ignite Creation Date:
2024-05-06 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06056921
Status:
RECRUITING
Last Update Posted:
2023-09-28
First Post:
2023-08-18
Brief Title:
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
Sponsor:
Chongqing Precision Biotech Co Ltd
Organization:
Chongqing Precision Biotech Co Ltd
Organization Data
Organization:
Chongqing Precision Biotech Co Ltd
Class:
INDUSTRY
Study ID:
PBC054
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chongqing Precision Biotech Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None